Investigation Report on Chinese Budesonide Market 2021-2025
No. of Pages: 50
Budesonide is an adrenal cortex hormone medicine. It is available in different forms, such as inhalant, nasal spray, and so on. The inhalation form is
|
09-Apr-2021
|
2600
|
Investigation Report on China's Ambroxol Market, 2021-2025
No. of Pages: 50
According to Researcher, the incidence and case fatality rate of respiratory diseases in China are high in recent years. Following cardiovascular and cerebrovascular diseases and
|
09-Apr-2021
|
2600
|
Investigation Report on Chinese Adalimumab Market, 2021-2025
No. of Pages: 40
In 2010, Adalimumab entered the Chinese market. Its original drug is produced by AbbVie Inc., under the brand name HUMIRA. The sales of HUMIRA is
|
09-Apr-2021
|
2600
|
Investigation Report on Chinese Bevacizumab Market 2021-2025
No. of Pages: 50
Bevacizumab is the world's first humanized monoclonal antibody for anti-tumor angiogenesis, which can be used to treat colon cancer and other solid tumors. AVASTIN, the
|
09-Apr-2021
|
2600
|
Investigation Report on China's Recombinant Lispro Insulin Market, 2021-2025
No. of Pages: 50
According to Researcher analysis, China’s rapid economic development in the past 30 years has brought about changes in people’s lifestyles, such as a reduction in
|
09-Apr-2021
|
2600
|
Investigation Report on Chinese Dezocine Market, 2021-2025
No. of Pages: 50
Dezocine is an opioid analgesic that relieves pain. Dezocine was launched in China in 2009 and has been widely used in general anesthesia induction, postoperative
|
09-Apr-2021
|
2600
|
Investigation Report on China's Hydroxychloroquine Market, 2021-2025
No. of Pages: 50
Hydroxychloroquine is commonly used to prevent and treat malaria. The pharmacokinetics of hydroxychloroquine is similar to that of chloroquine. It can be rapidly absorbed in
|
09-Apr-2021
|
2600
|
Investigation Report on Chinese Apixaban Market 2021-2025
No. of Pages: 50
Anticoagulation therapy plays an important role in the prevention and treatment of thromboembolic diseases. The two most famous drugs are Rivaroxaban and Apixaban, mainly used
|
09-Apr-2021
|
2600
|
Investigation Report on Chinese Pembrolizumab Market, 2021-2025
No. of Pages: 50
Pembrolizumab is a humanized PD-1 monoclonal antibody used for cancer immunotherapy. It currently has the most approved indications, as well as it is used in
|
09-Apr-2021
|
2600
|
Investigation Report on Chinese Atorvastatin Market 2021-2025
No. of Pages: 50
Atorvastatin is a common drug used to lower blood cholesterol levels. Its original drug, Lipitor (developed by Pfizer Inc), entered the Chinese market in 1999.
|
09-Apr-2021
|
2600
|
Pre-order Enquiry
Request Free Sample
